Mostrar el registro sencillo del ítem
A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis
dc.contributor.author | Herrera M.I. | |
dc.contributor.author | Kölliker-Frers R.A. | |
dc.contributor.author | Otero-Losada M. | |
dc.contributor.author | Perez Lloret S. | |
dc.contributor.author | Filippo M. | |
dc.contributor.author | Tau J. | |
dc.contributor.author | Capani F. | |
dc.contributor.author | Villa A.M. | |
dc.date.accessioned | 2020-09-02T22:20:27Z | |
dc.date.available | 2020-09-02T22:20:27Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.3389/fneur.2019.01046 | |
dc.identifier.citation | 10, , - | |
dc.identifier.issn | 16642295 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/4874 | |
dc.description | Objective: To test the feasibility of conducting a full-scale project evaluating the potential value of the phosphorylated neurofilament H (pNF-H) and several cytokines as disability markers in relapsing-remitting multiple sclerosis (RRMS). Methods: Twenty-four patients with 5-year RRMS evolution and eleven healthy control subjects entered the study. None of the participants had an inflammatory systemic or metabolic disease. Disability progression was evaluated using the Expanded Disability Status Scale. Serum level of pNF-H, the anti-inflammatory cytokine transforming growth factor-β 1 (TGF-β1), and the pro-inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-17A (IL-17A), monocyte chemotactic protein-1 (MCP-1), and soluble intercellular cell-adhesion molecule 1 (sICAM-1) were quantified using enzyme-linked immunosorbent assay (ELISA). Results: The patients had higher serum level of TGF-β1, IL-6, sICAM-1, and pNF-H. Based on these findings, a sample of at least 49 controls and 89 recent-onset RRMS patients is required to find an at least 1-point between-group difference in pNF-H with a power of 80% and an α error = 0.05. The progression of the disease was correlated with the level of pNF-H (Spearman rho = 0.624, p = 0.006), but not with the cytokines'. Conclusions: The serum level of pNF-H, EDSS score-correlated, might stand for a potential biomarker of disability in RRMS reflecting progressive axonal damage and cumulative neurological deterioration. The novelty of these results warrants conducting a larger confirmatory trial. © Copyright © 2019 Herrera, Kölliker-Frers, Otero-Losada, Perez Lloret, Filippo, Tau, Capani and Villa. | |
dc.language.iso | en | |
dc.publisher | Frontiers Media S.A. | |
dc.subject | biomarker potential | |
dc.subject | cytokines | |
dc.subject | disability progression | |
dc.subject | expanded disability status scale | |
dc.subject | neurofilament heavy chain phosphoform | |
dc.subject | relapsing-remitting multiple sclerosis | |
dc.subject | cytokine | |
dc.subject | intercellular adhesion molecule 1 | |
dc.subject | interleukin 17 | |
dc.subject | interleukin 1beta | |
dc.subject | interleukin 6 | |
dc.subject | interleukin 8 | |
dc.subject | monocyte chemotactic protein 1 | |
dc.subject | neurofilament H protein | |
dc.subject | neurofilament protein | |
dc.subject | transforming growth factor beta1 | |
dc.subject | tumor necrosis factor | |
dc.subject | unclassified drug | |
dc.subject | adult | |
dc.subject | Article | |
dc.subject | axonal injury | |
dc.subject | case study | |
dc.subject | clinical article | |
dc.subject | clinical evaluation | |
dc.subject | controlled study | |
dc.subject | correlational study | |
dc.subject | cross-sectional study | |
dc.subject | deterioration | |
dc.subject | disease exacerbation | |
dc.subject | disease marker | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | Expanded Disability Status Scale | |
dc.subject | feasibility study | |
dc.subject | female | |
dc.subject | human | |
dc.subject | immunomodulation | |
dc.subject | male | |
dc.subject | metabolic disorder | |
dc.subject | multiple sclerosis | |
dc.subject | observational study | |
dc.subject | pilot study | |
dc.subject | protein blood level | |
dc.subject | protein phosphorylation | |
dc.subject | scoring system | |
dc.title | A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis | |
dc.type | Article |